CAS 335161-24-5
:AM 2201
- Am 2201
- Jwh 2201
- [1-(5-Fluoropentyl)-1H-Indol-3-Yl]-1-Naphthalenylmethanone
- Methanone, [1-(5-fluoropentyl)-1H-indol-3-yl]-1-naphthalenyl-
AM-2201 ((1-(5-Fluoropentyl)indol-3-yl)(naphthalen-1-yl)methanone) 0.1 mg/ml in Acetonitrile
CAS:Controlled ProductColor and Shape:Single SolutionAM-2201 ((1-(5-Fluoropentyl)indol-3-yl)(naphthalen-1-yl)methanone) 1.0 mg/ml in Acetonitrile
CAS:Controlled ProductColor and Shape:Single SolutionAM-2201
CAS:Controlled ProductApplications It is a drug which acts as a potent but unselective agonist for the cannabinoid receptor CB1 or CB2.Synthetic Cannabinoids
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Yamada., et al.: J. Med. Chem., 39, 1967 (1996),Formula:C24H22FNOColor and Shape:NeatMolecular weight:359.44AM-2201 (1.0 mg/ml in Methanol)
CAS:Controlled ProductFormula:C24H22FNOColor and Shape:Single SolutionMolecular weight:359.44AM 2201
CAS:Controlled ProductAM-2201 is a potent, non-selective synthetic cannabinoid of the aminoalkylindole type which acts as a full agonist at cannabinoid receptors CB1 and CB2 (EC50 = 38 nM and 58 nM, respectively)1. AM-2201 metabolites are also recognised to be full agonists1. Binding to the cannabinoid receptors triggers a reduction of intracellular cAMP levels by inhibiting adenylate cyclase2. In vitro studies have shown 41 and 18 times more affinity for CB1 and CB2 receptors, respectively, when compared to Δ9-THC and revealed dosage-dependent cytotoxicity and chromosomal aberrations in primary cell lines3. Studies on experimental mice models showed bradycardia, hypothermia, and catalepsy1.
Formula:C24H22FNOPurity:Min. 95%Molecular weight:359.44 g/mol


